Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2006-10-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery
NCT02163408
Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)
NCT00353795
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
NCT02265250
Imaging of Plaque With Magnetic Resonance Imaging (MRI)
NCT00115856
Magnetic Resonance Imaging (MRI) Analysis of Coronary Artery Plaque Components
NCT00559728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surgical carotid artery disease
* Provide written informed consent and Authorization for Use/Disclosure of PHI
Exclusion Criteria
* History of middle or large vessel vasculitis
* Refusal to provide written informed consent and Authorization for
* Use/Disclosure of PHI
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Piedmont Healthcare
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Rinehart, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Rinehart, MD
Role: PRINCIPAL_INVESTIGATOR
Piedmont Healthcare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Piedmont Hospital
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P06-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.